메뉴 건너뛰기




Volumn 15, Issue 1, 2008, Pages 29-39

Enhancement of antitumor activity of cisplatin in human lung cancer cells by tumor suppressor FUS1

Author keywords

Cisplatin; FUS1; Lung cancer

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CISPLATIN; NANOCARRIER; PROTEIN MDM2; PROTEIN P53;

EID: 37149046928     PISSN: 09291903     EISSN: 14765500     Source Type: Journal    
DOI: 10.1038/sj.cgt.7701094     Document Type: Article
Times cited : (32)

References (45)
  • 2
    • 0034175738 scopus 로고    scopus 로고
    • Novel approaches to locally advanced unresectable non-small cell lung cancer
    • Stevens CW, Lee JS, Cox J, Komaki R. Novel approaches to locally advanced unresectable non-small cell lung cancer. Radiother Oncol 2000; 55: 11-18.
    • (2000) Radiother Oncol , vol.55 , pp. 11-18
    • Stevens, C.W.1    Lee, J.S.2    Cox, J.3    Komaki, R.4
  • 4
    • 0030292602 scopus 로고    scopus 로고
    • Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small-cell lung cancer - a meta-analysis
    • Pritchard RS, Anthony SP. Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small-cell lung cancer - a meta-analysis. Ann Intern Med 1996; 125: 723-729.
    • (1996) Ann Intern Med , vol.125 , pp. 723-729
    • Pritchard, R.S.1    Anthony, S.P.2
  • 5
    • 19944427144 scopus 로고    scopus 로고
    • The effects of cetuximab alone and in combination with radiation and/or chemotherapy in lung cancer
    • Raben D, Helfrich B, Chan DC, Ciardiello F, Zhao L, Franklin W et al. The effects of cetuximab alone and in combination with radiation and/or chemotherapy in lung cancer. Clin Cancer Res 2005; 11: 795-805.
    • (2005) Clin Cancer Res , vol.11 , pp. 795-805
    • Raben, D.1    Helfrich, B.2    Chan, D.C.3    Ciardiello, F.4    Zhao, L.5    Franklin, W.6
  • 6
    • 10644233929 scopus 로고    scopus 로고
    • Platinum-intercalator conjugates: From DNA-targeted cisplatin derivatives to adenine binding complexes as potential modulators of gene regulation
    • Baruah H, Barry CG, Bierbach U. Platinum-intercalator conjugates: from DNA-targeted cisplatin derivatives to adenine binding complexes as potential modulators of gene regulation. Curr Top Med Chem 2004; 4: 1537-1549.
    • (2004) Curr Top Med Chem , vol.4 , pp. 1537-1549
    • Baruah, H.1    Barry, C.G.2    Bierbach, U.3
  • 7
    • 0032692490 scopus 로고    scopus 로고
    • Docetaxel (Taxotere) in combination chemotherapy and in association with thoracic radiotherapy for the treatment of non-small-cell lung cancer
    • Ornstein DL, Nervi AM, Rigas JR. Docetaxel (Taxotere) in combination chemotherapy and in association with thoracic radiotherapy for the treatment of non-small-cell lung cancer. Ann Oncol 1999; 10(Suppl 5): S35-S40.
    • (1999) Ann Oncol , vol.10 , Issue.SUPPL. 5
    • Ornstein, D.L.1    Nervi, A.M.2    Rigas, J.R.3
  • 9
    • 19244370711 scopus 로고    scopus 로고
    • High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints
    • Wistuba II, Behrens C, Virmani AK, Mele G, Milchgrub S, Girard L et al. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Cancer Res 2000; 60: 1949-1960.
    • (2000) Cancer Res , vol.60 , pp. 1949-1960
    • Wistuba, I.I.1    Behrens, C.2    Virmani, A.K.3    Mele, G.4    Milchgrub, S.5    Girard, L.6
  • 11
    • 0034327412 scopus 로고    scopus 로고
    • The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: Identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium
    • Lerman MI, Minna JD. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. Cancer Res 2000; 60: 6116-6133.
    • (2000) Cancer Res , vol.60 , pp. 6116-6133
    • Lerman, M.I.1    Minna, J.D.2
  • 12
    • 0037037787 scopus 로고    scopus 로고
    • Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers
    • Zabarovsky ER, Lerman MI, Minna JD. Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers. Oncogene 2002; 21: 6915-6935.
    • (2002) Oncogene , vol.21 , pp. 6915-6935
    • Zabarovsky, E.R.1    Lerman, M.I.2    Minna, J.D.3
  • 13
    • 0036569946 scopus 로고    scopus 로고
    • Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo
    • Ji L, Nishizaki M, Gao B, Burbee D, Kondo M, Kamibayashi C et al. Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo. Cancer Res 2002; 62: 2715-2720.
    • (2002) Cancer Res , vol.62 , pp. 2715-2720
    • Ji, L.1    Nishizaki, M.2    Gao, B.3    Burbee, D.4    Kondo, M.5    Kamibayashi, C.6
  • 14
    • 0035959880 scopus 로고    scopus 로고
    • Overexpression of candidate tumor suppressor gene FUS1 isolated from the 3p21.3 homozygous deletion region leads to G1 arrest and growth inhibition of lung cancer cells
    • Kondo M, Ji L, Kamibayashi C, Tomizawa Y, Randle D, Sekido Y et al. Overexpression of candidate tumor suppressor gene FUS1 isolated from the 3p21.3 homozygous deletion region leads to G1 arrest and growth inhibition of lung cancer cells. Oncogene 2001; 20: 6258-6262.
    • (2001) Oncogene , vol.20 , pp. 6258-6262
    • Kondo, M.1    Ji, L.2    Kamibayashi, C.3    Tomizawa, Y.4    Randle, D.5    Sekido, Y.6
  • 15
    • 2342472611 scopus 로고    scopus 로고
    • Myristoylation of the FUS1 protein is required for tumor suppression in human lung cancer cells
    • Uno F, Sasaki J, Nishizaki M, Carboni G, Xu K, Atkinson EN et al. Myristoylation of the FUS1 protein is required for tumor suppression in human lung cancer cells. Cancer Res 2004; 64: 2969-2976.
    • (2004) Cancer Res , vol.64 , pp. 2969-2976
    • Uno, F.1    Sasaki, J.2    Nishizaki, M.3    Carboni, G.4    Xu, K.5    Atkinson, E.N.6
  • 16
    • 8444251047 scopus 로고    scopus 로고
    • Liposomal vector mediated delivery of the 3p FUS1 gene demonstrates potent antitumor activity against human lung cancer in vivo
    • Ito I, Ji L, Tanaka F, Saito Y, Gopalan B, Branch CD et al. Liposomal vector mediated delivery of the 3p FUS1 gene demonstrates potent antitumor activity against human lung cancer in vivo. Cancer Gene Ther 2004; 11: 733-739.
    • (2004) Cancer Gene Ther , vol.11 , pp. 733-739
    • Ito, I.1    Ji, L.2    Tanaka, F.3    Saito, Y.4    Gopalan, B.5    Branch, C.D.6
  • 17
    • 1042264041 scopus 로고    scopus 로고
    • Gene replacement therapy for non-small cell lung cancer: A review
    • Roth JA, Grammer SF. Gene replacement therapy for non-small cell lung cancer: a review. Hematol Oncol Clin North Am 2004; 18: 215-229.
    • (2004) Hematol Oncol Clin North Am , vol.18 , pp. 215-229
    • Roth, J.A.1    Grammer, S.F.2
  • 18
    • 37149010839 scopus 로고    scopus 로고
    • Adenovirus-mediated cancer gene therapy
    • Hunt K ed, Humana Press: Totowa, NJ
    • Fang B, Roth JA. Adenovirus-mediated cancer gene therapy. In: Hunt K (ed). Gene Therapy for Cancer. Humana Press: Totowa, NJ, 2005.
    • (2005) Gene Therapy for Cancer
    • Fang, B.1    Roth, J.A.2
  • 19
    • 0034085044 scopus 로고    scopus 로고
    • Synergistic effects of adenovirus expressing wild-type p53 on chemosensitivity of non-small cell lung cancer cells
    • Horio Y, Hasegawa Y, Sekido Y, Takahashi M, Roth JA, Shimokata K. Synergistic effects of adenovirus expressing wild-type p53 on chemosensitivity of non-small cell lung cancer cells. Cancer Gene Ther 2000; 7: 537-544.
    • (2000) Cancer Gene Ther , vol.7 , pp. 537-544
    • Horio, Y.1    Hasegawa, Y.2    Sekido, Y.3    Takahashi, M.4    Roth, J.A.5    Shimokata, K.6
  • 20
    • 0032902502 scopus 로고    scopus 로고
    • Recombinant adenovirus expressing wild-type p53 is antiangiogenic: A proposed mechanism for by stander effects
    • Nishizaki M, Fujiwara T, Tanida T, Hizuta A, Nishimori H, Tokino T et al. Recombinant adenovirus expressing wild-type p53 is antiangiogenic: a proposed mechanism for by stander effects. Clin Cancer Res 1999; 5: 1015-1023.
    • (1999) Clin Cancer Res , vol.5 , pp. 1015-1023
    • Nishizaki, M.1    Fujiwara, T.2    Tanida, T.3    Hizuta, A.4    Nishimori, H.5    Tokino, T.6
  • 21
    • 0029856574 scopus 로고    scopus 로고
    • Adenoviral-mediated wild-type p53 gene expression sensitizes colorectal cancer cells to ionizing radiation
    • Spitz FR, Nguyen D, Skibber JM, Meyn RE, Cristiano RJ, Roth JA. Adenoviral-mediated wild-type p53 gene expression sensitizes colorectal cancer cells to ionizing radiation. Clin Cancer Res 1996; 2: 1665-1671.
    • (1996) Clin Cancer Res , vol.2 , pp. 1665-1671
    • Spitz, F.R.1    Nguyen, D.2    Skibber, J.M.3    Meyn, R.E.4    Cristiano, R.J.5    Roth, J.A.6
  • 22
    • 0028231586 scopus 로고
    • Induction of chemosensitivity in human lung cancer cells in vivo by adenoviral-mediated transfer of the wild-type p53 gene
    • Fujiwara T, Grimm EA, Mukhopadhyay T, Zhang WW, Owen-Schaub LB, Roth JA. Induction of chemosensitivity in human lung cancer cells in vivo by adenoviral-mediated transfer of the wild-type p53 gene. Cancer Res 1994; 54: 2287-2291.
    • (1994) Cancer Res , vol.54 , pp. 2287-2291
    • Fujiwara, T.1    Grimm, E.A.2    Mukhopadhyay, T.3    Zhang, W.W.4    Owen-Schaub, L.B.5    Roth, J.A.6
  • 23
    • 0034814353 scopus 로고    scopus 로고
    • Synergistic inhibition of human lung cancer cell growth by adenovirus-mediated wild-type p53 gene transfer in combination with docetaxel and radiation therapeutics in vitro and in vivo
    • Nishizaki M, Meyn RE, Levy LB, Atkinson EN, White RA, Roth JA et al. Synergistic inhibition of human lung cancer cell growth by adenovirus-mediated wild-type p53 gene transfer in combination with docetaxel and radiation therapeutics in vitro and in vivo. Clin Cancer Res 2001; 7: 2887-2897.
    • (2001) Clin Cancer Res , vol.7 , pp. 2887-2897
    • Nishizaki, M.1    Meyn, R.E.2    Levy, L.B.3    Atkinson, E.N.4    White, R.A.5    Roth, J.A.6
  • 24
    • 33750330930 scopus 로고    scopus 로고
    • The 3p21.3 tumor suppressor NPRL2 plays an important role in cisplatin-induced resistance in human NSCLC cells
    • Ueda K, Kawashima H, Ohtani S, Deng WG, Ravoori M, Bankson J et al. The 3p21.3 tumor suppressor NPRL2 plays an important role in cisplatin-induced resistance in human NSCLC cells. Cancer Res 2006; 66: 9682-9690.
    • (2006) Cancer Res , vol.66 , pp. 9682-9690
    • Ueda, K.1    Kawashima, H.2    Ohtani, S.3    Deng, W.G.4    Ravoori, M.5    Bankson, J.6
  • 25
    • 0027451668 scopus 로고
    • p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
    • Lowe SW, Ruley HE, Jacks T, Housman DE. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993; 74: 957-967.
    • (1993) Cell , vol.74 , pp. 957-967
    • Lowe, S.W.1    Ruley, H.E.2    Jacks, T.3    Housman, D.E.4
  • 26
    • 0036468550 scopus 로고    scopus 로고
    • Dysfunctional apoptosome activation in ovarian cancer: Implications for chemoresistance
    • Liu JR, Opipari AW, Tan L, Jiang Y, Zhang Y, Tang H et al. Dysfunctional apoptosome activation in ovarian cancer: implications for chemoresistance. Cancer Res 2002; 62: 924-931.
    • (2002) Cancer Res , vol.62 , pp. 924-931
    • Liu, J.R.1    Opipari, A.W.2    Tan, L.3    Jiang, Y.4    Zhang, Y.5    Tang, H.6
  • 27
    • 0029941463 scopus 로고    scopus 로고
    • Apoptosis and chemotherapy resistance
    • Hickman JA. Apoptosis and chemotherapy resistance. Eur J Cancer 1996; 32A: 921-926.
    • (1996) Eur J Cancer , vol.32 A , pp. 921-926
    • Hickman, J.A.1
  • 28
    • 33646499218 scopus 로고    scopus 로고
    • Upregulation of Bcl-2 is associated with cisplatin-resistance via inhibition of Bax translocation in human bladder cancer cells
    • Cho HJ, Kim JK, Kim KD, Yoon HK, Cho MY, Park YP et al. Upregulation of Bcl-2 is associated with cisplatin-resistance via inhibition of Bax translocation in human bladder cancer cells. Cancer Lett 2006; 237: 56-66.
    • (2006) Cancer Lett , vol.237 , pp. 56-66
    • Cho, H.J.1    Kim, J.K.2    Kim, K.D.3    Yoon, H.K.4    Cho, M.Y.5    Park, Y.P.6
  • 29
    • 0345256652 scopus 로고    scopus 로고
    • Cisplatin: Mode of cytotoxic action and molecular basis of resistance
    • Siddik ZH. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 2003; 22: 7265-7279.
    • (2003) Oncogene , vol.22 , pp. 7265-7279
    • Siddik, Z.H.1
  • 30
    • 0031820832 scopus 로고    scopus 로고
    • Alteration in p53 pathway and defect in apoptosis contribute independently to cisplatin- resistance
    • Segal-Bendirdjian E, Mannone L, Jacquemin-Sablon A. Alteration in p53 pathway and defect in apoptosis contribute independently to cisplatin- resistance. Cell Death Differ 1998; 5: 390-400.
    • (1998) Cell Death Differ , vol.5 , pp. 390-400
    • Segal-Bendirdjian, E.1    Mannone, L.2    Jacquemin-Sablon, A.3
  • 31
    • 0031014097 scopus 로고    scopus 로고
    • Identification of p53 genetic suppressor elements which confer resistance to cisplatin
    • Gallagher WM, Cairney M, Schott B, Gallagher WM, Cairney M, Schott B et al. Identification of p53 genetic suppressor elements which confer resistance to cisplatin. Oncogene 1997; 14: 185-193.
    • (1997) Oncogene , vol.14 , pp. 185-193
    • Gallagher, W.M.1    Cairney, M.2    Schott, B.3    Gallagher, W.M.4    Cairney, M.5    Schott, B.6
  • 32
    • 0035206720 scopus 로고    scopus 로고
    • Identification of genes that mediate sensitivity to cisplatin
    • Niedner H, Christen R, Lin X, Kondo A, Howell SB. Identification of genes that mediate sensitivity to cisplatin. Mol Pharmacol 2001; 60: 1153-1160.
    • (2001) Mol Pharmacol , vol.60 , pp. 1153-1160
    • Niedner, H.1    Christen, R.2    Lin, X.3    Kondo, A.4    Howell, S.B.5
  • 33
    • 0035840335 scopus 로고    scopus 로고
    • Bcl-2 blocks cisplatin-induced apoptosis by suppression of ERK-mediated p53 accumulation in B104 cells
    • Park SA, Park HJ, Lee BI, Ahn YH, Kim SU, Choi KS. Bcl-2 blocks cisplatin-induced apoptosis by suppression of ERK-mediated p53 accumulation in B104 cells. Brain Res Mol Brain Res 2001; 93: 18-26.
    • (2001) Brain Res Mol Brain Res , vol.93 , pp. 18-26
    • Park, S.A.1    Park, H.J.2    Lee, B.I.3    Ahn, Y.H.4    Kim, S.U.5    Choi, K.S.6
  • 34
    • 0033552613 scopus 로고    scopus 로고
    • Regulation of p53 stability
    • Ashcroft M, Vousden KH. Regulation of p53 stability. Oncogene 1999; 18: 7637-7643.
    • (1999) Oncogene , vol.18 , pp. 7637-7643
    • Ashcroft, M.1    Vousden, K.H.2
  • 35
    • 0032952004 scopus 로고    scopus 로고
    • Mdm2: The ups and downs
    • Juven-Gershon T, Oren M. Mdm2: the ups and downs. Mol Med 1999; 5: 71-83.
    • (1999) Mol Med , vol.5 , pp. 71-83
    • Juven-Gershon, T.1    Oren, M.2
  • 37
    • 0032475878 scopus 로고    scopus 로고
    • Signaling to p53: Breaking the MDM2-p53 circuit
    • Prives C. Signaling to p53: breaking the MDM2-p53 circuit. Cell 1998; 95: 5-8.
    • (1998) Cell , vol.95 , pp. 5-8
    • Prives, C.1
  • 38
    • 0030981049 scopus 로고    scopus 로고
    • A genetic approach to mapping the p53 binding site in the MDM2 protein
    • Freedman DA, Epstein CB, Roth JC, Levine AJ. A genetic approach to mapping the p53 binding site in the MDM2 protein. Mol Med 1997; 3: 248-259.
    • (1997) Mol Med , vol.3 , pp. 248-259
    • Freedman, D.A.1    Epstein, C.B.2    Roth, J.C.3    Levine, A.J.4
  • 39
    • 0031939875 scopus 로고    scopus 로고
    • Synergistic activation of p53 by inhibition of MDM2 expression and DNA damage
    • Chen L, Agrawal S, Zhou W, Zhang R, Chen J. Synergistic activation of p53 by inhibition of MDM2 expression and DNA damage. Proc Natl Acad Sci USA 1998; 95: 195-200.
    • (1998) Proc Natl Acad Sci USA , vol.95 , pp. 195-200
    • Chen, L.1    Agrawal, S.2    Zhou, W.3    Zhang, R.4    Chen, J.5
  • 40
    • 0030965946 scopus 로고    scopus 로고
    • Regulation of p53 stability by Mdm2
    • Kubbutat MH, Jones SN, Vousden KH. Regulation of p53 stability by Mdm2. Nature 1997; 387: 299-303.
    • (1997) Nature , vol.387 , pp. 299-303
    • Kubbutat, M.H.1    Jones, S.N.2    Vousden, K.H.3
  • 42
    • 0036204110 scopus 로고    scopus 로고
    • The regulation of APAF1 expression during development and tumourigenesis
    • Hickman ES, Helin K. The regulation of APAF1 expression during development and tumourigenesis. Apoptosis 2002; 7: 167-171.
    • (2002) Apoptosis , vol.7 , pp. 167-171
    • Hickman, E.S.1    Helin, K.2
  • 45
    • 0035860419 scopus 로고    scopus 로고
    • Apaf-1 overexpression partially overcomes apoptotic resistance in a cisplatin-selected HeLa cell line
    • Kamarajan P, Sun NK, Sun CL, Chao CC. Apaf-1 overexpression partially overcomes apoptotic resistance in a cisplatin-selected HeLa cell line. FEBS Lett 2001; 505: 206-212.
    • (2001) FEBS Lett , vol.505 , pp. 206-212
    • Kamarajan, P.1    Sun, N.K.2    Sun, C.L.3    Chao, C.C.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.